COMPARATIVE EFFICACY OF HALOPERIDOL AND RISPERIDONE: A REVIEW

作者: Rafeeq Alam Khan , Afshan Siddiq , Sadia Ghousia Baig , Shahida Perveen Ahmed

DOI:

关键词: PsychiatrySchizophreniaHaloperidolLysergic acid diethylamidePsychotropic AgentClinical psychologyRisperidonePsychosisAntipsychoticDopamine antagonistPsychology

摘要: Psychosis is a mental state of illness in which person detached from reality. many form, including; Hallucinations, Delusions, thought insertion, withdrawal, block broadcasting, lack insight etc. Different theories suggest that the cause psychotic may be, inherited, problem brain, neurochemical imbalance, anxiety or stress, any combination above, using drugs [e.g., cannabis, Lysergic acid diethylamide (LSD)], infections (e.g., menningitis), brain tumours (cancer), epilepsy, head injuries. has been shown to respond well treatments such as antipsychotic medication, and more recently cognitive-behavioural therapy suggested working well. Family group therapies are often found give successful results certain individuals. Haloperidol psychotropic agent indicated for treatment schizophrenia. It also exerts sedative antiemetic activity. actions at all levels central nervous system-primarily subcortical on multiple organ systems. Risperidone novel antipsychotics, it uniquely balanced serotonin/dopamine antagonist (SDA) offers considerable advantages first-line This review examines efficacy haloperidol versus risperidone.

参考文章(49)
V P Zykov, O I Begasheva, I B Komarova, E K Nazarova, S A Kabanova, Autonomic cardiovascular regulation in patients with tics and Tourette syndrome Zhurnal Nevrologii I Psikhiatrii Imeni S S Korsakova. ,vol. 105, pp. 18- 22 ,(2005)
Alvarez Gf, Skowronski Ga, Remember the side effects of haloperidol: a case report. Critical Care and Resuscitation. ,vol. 5, pp. 266- ,(2003)
Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss, Josef Marksteiner, Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Safety. ,vol. 29, pp. 587- 598 ,(2006) , 10.2165/00002018-200629070-00004
Obaid Ali, Syed Waseemuddin Ahmed, Roohi Obaid, Darakshan J Haleem, Noor Kamil, Mohammed A Haleem, Effect of co administration of haloperidol and large neutral amino acids (tryptophan and valine) on rats striatal dopamine, serotonin and their metabolism. Pakistan Journal of Pharmaceutical Sciences. ,vol. 16, pp. 13- 25 ,(2003)
Matteo Balestrieri, Claudio Vampini, Cesario Bellantuono, Efficacy and safety of novel antipsychotics: a critical review Human Psychopharmacology-clinical and Experimental. ,vol. 15, pp. 499- 512 ,(2000) , 10.1002/1099-1077(200010)15:7<499::AID-HUP194>3.0.CO;2-3
Anders Fredriksson, Trevor Archer, Subchronic administration of haloperidol influences the functional deficits of postnatal iron administration in Mice Neurotoxicity Research. ,vol. 9, pp. 123- 129 ,(2006) , 10.1007/BF03033321
David Garver, Evolution of antipsychotic intervention in the schizophrenic psychosis. Current Drug Targets. ,vol. 7, pp. 1205- 1215 ,(2006) , 10.2174/138945006778226543
R. Galili-Mosberg, I. Gil-Ad, A. Weizman, E. Melamed, D. Offen, Haloperidol-induced neurotoxicity--possible implications for tardive dyskinesia. Journal of Neural Transmission. ,vol. 107, pp. 479- 490 ,(2000) , 10.1007/S007020070089
Claudia St??llberger, Johannes O. Huber, Josef Finsterer, Antipsychotic drugs and QT prolongation. International Clinical Psychopharmacology. ,vol. 20, pp. 243- 251 ,(2005) , 10.1097/01.YIC.0000166405.49473.70